Janssen Submits Additional Marketing Applications for ZYTIGA® in the European Union and in the U.S. – Bloomberg

This study, which included 1,088 asymptomatic or mildly symptomatic men with mCRPC who had not received chemotherapy, evaluated the effect of ZYTIGA plus prednisone on the co-primary endpoints of radiographic progression-free survival (rPFS …